NL-OMON26148尚未招募不适用
ADMINISTRATION OF HA-1 TCR RANSDUCED VIRUS-SPECIFIC T-CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK LEUKEMIA.
eiden University Medical Center (LUMC)0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18-75 years;
- •2. WHO performance score 0-2;
排除标准
- •1. Life expectation < 3 months;
- •2. End stage irreversible multi-system organ failure;
研究者
相似试验
进行中（未招募）
1 期
ADMINISTRATION OF HA-1 TCR TRANSDUCED VIRUS-SPECIFIC T-CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK LEUKEMIAhigh risk leukemiaEUCTR2010-024625-20-NLeiden University Medical Center20
已完成
2 期
ADMINISTRATION OF HA-1 TCR TRANSDUCED VIRUS-SPECIFIC T-CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK LEUKEMIA (LUMC 2010-02)10024324leukemiahematological malignancyNL-OMON38068eids Universitair Medisch Centrum9
进行中（未招募）
1 期
Phase I/II trial for vaccine therapy with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion in patients with metastatic malignant melanomaEUCTR2008-006253-41-NOThe Norwegian Radium Hospital, Oslo University Hospital25
尚未招募
不适用
TCR repertoire analysis after Hepatitis A vaccinatioAgeingImmune response with ageTCR repertoire10027665NL-OMON56630niversitair Medisch Centrum Utrecht145
已完成
不适用
Vaccination with human minor H antigen (HA-1) peptide after allogeneic stem cell transplantatioISRCTN80896844eiden University Medical Centre (LUMC) (Netherlands)24